Kite to Present at June 2017 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that management will present at two investor conferences in June 2017:

• Jefferies 2017 Global Healthcare ConferenceWednesday, June 71:30pm Eastern TimeNew York, NY
• Goldman Sachs 38^th Annual Global Healthcare ConferenceTuesday, June 132:00pm Pacific TimeRancho Palos Verdes, CA

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170606005247/en/

KiteChristine CassianoSVP, Corporate Communications & Investor Relationsccassiano@kitepharma.comorGreg MannVP, Investor Relationsgmann@kitepharma.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media